In the last 12 months, insiders at uniQure N.V. ($QURE) filed 215 transactions with the SEC: 0 open-market purchases totaling $0 and 98 sales totaling $19,944,258. Net insider sentiment: net selling.
uniQure N.V. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Kapusta Matthew C (CEO, Managing Director) — 35 transactions totaling $16,005,563
- KLEMT CHRISTIAN (Chief Financial Officer) — 30 transactions totaling $2,140,342
- Gut Robert (Director) — 20 transactions totaling $1,978,515
- Kaye Jack (Director) — 24 transactions totaling $1,952,073
- CALOZ PIERRE (Chief Operating Officer) — 12 transactions totaling $408,646
View all SEC Filings for uniQure N.V. (QURE).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | O'Keefe Kylie | Chief Customer & Strat Officer | A | Stock Option (Right to Buy) | 31900 | $0.00 | 31,900.0000 | 57,502,068 | 9999.99% | 0.06% |
| March 4, 2026 | O'Keefe Kylie | Chief Customer & Strat Officer | A | Ordinary Shares | 19800 | $0.00 | 124,800.0000 | 57,502,068 | 18.86% | 0.03% |
| March 4, 2026 | KLEMT CHRISTIAN | Chief Financial Officer | A | Ordinary Shares | 39600 | $0.00 | 238,581.0000 | 57,502,068 | 19.90% | 0.07% |
| March 4, 2026 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 12000 | $9.06 | 226,581.0000 | 57,502,068 | 5.03% | 0.02% |
| March 4, 2026 | KLEMT CHRISTIAN | Chief Financial Officer | A | Stock Option (Right to Buy) | 63900 | $0.00 | 63,900.0000 | 57,502,068 | 9999.99% | 0.11% |
| March 4, 2026 | Kapusta Matthew C | CEO, Managing Director | A | Ordinary Shares | 70600 | $0.00 | 675,239.0000 | 57,502,068 | 11.68% | 0.12% |
| March 4, 2026 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 14581 | $9.06 | 660,658.0000 | 57,502,068 | 2.16% | 0.03% |
| March 4, 2026 | Kapusta Matthew C | CEO, Managing Director | A | Stock Option (Right to Buy) | 113800 | $0.00 | 113,800.0000 | 57,502,068 | 9999.99% | 0.20% |
| March 4, 2026 | Abi-Saab Walid | Chief Medical Officer | A | Ordinary Shares | 41700 | $0.00 | 190,477.0000 | 57,502,068 | 28.03% | 0.07% |
| March 4, 2026 | Abi-Saab Walid | Chief Medical Officer | S | Ordinary Shares | 808 | $9.06 | 189,669.0000 | 57,502,068 | 0.42% | 0.00% |
| March 4, 2026 | Abi-Saab Walid | Chief Medical Officer | A | Stock Option (Right to Buy) | 67200 | $0.00 | 67,200.0000 | 57,502,068 | 9999.99% | 0.12% |
| March 4, 2026 | Potts Jeannette | Chief Legal Officer | A | Ordinary Shares | 35400 | $0.00 | 141,895.0000 | 57,502,068 | 33.24% | 0.06% |
| March 4, 2026 | Potts Jeannette | Chief Legal Officer | S | Ordinary Shares | 3412 | $9.06 | 138,483.0000 | 57,502,068 | 2.40% | 0.01% |
| March 4, 2026 | Potts Jeannette | Chief Legal Officer | A | Stock Option (Right to Buy) | 57200 | $0.00 | 57,200.0000 | 57,502,068 | 9999.99% | 0.10% |
| March 2, 2026 | Abi-Saab Walid | Chief Medical Officer | S | Ordinary Shares | 1660 | $9.95 | 148,777.0000 | 57,502,068 | 1.10% | 0.00% |
| March 2, 2026 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 34437 | $9.95 | 604,639.0000 | 57,502,068 | 5.39% | 0.06% |
| March 2, 2026 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 12532 | $9.95 | 198,981.0000 | 57,502,068 | 5.92% | 0.02% |
| March 2, 2026 | Potts Jeannette | Chief Legal Officer | S | Ordinary Shares | 8578 | $9.95 | 106,495.0000 | 57,502,068 | 7.45% | 0.01% |
| Feb. 25, 2026 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 6217 | $23.86 | 211,513.0000 | 57,502,068 | 2.86% | 0.01% |
| Feb. 25, 2026 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 12378 | $23.86 | 639,076.0000 | 57,502,068 | 1.90% | 0.02% |
| Jan. 12, 2026 | Gut Robert | Director | S | Ordinary Shares | 7803 | $25.09 | 32,342.0000 | 57,502,068 | 19.44% | 0.01% |
| Jan. 12, 2026 | Gut Robert | Director | M | Stock Option (Right to Buy) | 17810 | $0.00 | 0.0000 | 57,502,068 | 100.00% | 0.03% |
| Jan. 12, 2026 | Gut Robert | Director | M | Ordinary Shares | 17810 | $14.08 | 57,955.0000 | 57,502,068 | 44.36% | 0.03% |
| Jan. 12, 2026 | Gut Robert | Director | S | Ordinary Shares | 17310 | $24.39 | 40,645.0000 | 57,502,068 | 29.87% | 0.03% |
| Jan. 12, 2026 | Gut Robert | Director | S | Ordinary Shares | 500 | $25.03 | 40,145.0000 | 57,502,068 | 1.23% | 0.00% |
| Jan. 9, 2026 | Kaye Jack | Director | M | Ordinary Shares | 6390 | $19.39 | 26,829.0000 | 57,502,068 | 31.26% | 0.01% |
| Jan. 9, 2026 | Kaye Jack | Director | M | Stock Option (Right to Buy) | 6390 | $0.00 | 0.0000 | 57,502,068 | 100.00% | 0.01% |
| Jan. 9, 2026 | Kaye Jack | Director | S | Ordinary Shares | 6390 | $27.28 | 20,439.0000 | 57,502,068 | 23.82% | 0.01% |
| Nov. 6, 2025 | Gut Robert | Director | M | Ordinary Shares | 15840 | $4.57 | 71,579.0000 | 58,516,415 | 28.42% | 0.03% |
| Nov. 6, 2025 | Gut Robert | Director | S | Ordinary Shares | 15594 | $27.30 | 40,145.0000 | 58,516,415 | 27.98% | 0.03% |
| Nov. 6, 2025 | Gut Robert | Director | M | Stock Option (Right to Buy) | 15840 | $0.00 | 0.0000 | 58,516,415 | 100.00% | 0.03% |
| Nov. 6, 2025 | Gut Robert | Director | S | Ordinary Shares | 15840 | $27.22 | 55,739.0000 | 58,516,415 | 22.13% | 0.03% |
| Nov. 4, 2025 | Kaye Jack | Director | M | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 58,516,415 | 100.00% | 0.02% |
| Nov. 4, 2025 | Kaye Jack | Director | M | Stock Option (Right to Buy) | 17810 | $0.00 | 0.0000 | 58,516,415 | 100.00% | 0.03% |
| Nov. 4, 2025 | Kaye Jack | Director | M | Stock Option (Right to Buy) | 11000 | $0.00 | 0.0000 | 58,516,415 | 100.00% | 0.02% |
| Nov. 4, 2025 | Kaye Jack | Director | S | Ordinary Shares | 17810 | $30.33 | 20,439.0000 | 58,516,415 | 46.56% | 0.03% |
| Nov. 4, 2025 | Kaye Jack | Director | M | Ordinary Shares | 17810 | $14.08 | 38,249.0000 | 58,516,415 | 87.14% | 0.03% |
| Nov. 4, 2025 | Kaye Jack | Director | S | Ordinary Shares | 11000 | $30.34 | 20,439.0000 | 58,516,415 | 34.99% | 0.02% |
| Nov. 4, 2025 | Kaye Jack | Director | M | Ordinary Shares | 11000 | $5.37 | 31,439.0000 | 58,516,415 | 53.82% | 0.02% |
| Nov. 4, 2025 | Kaye Jack | Director | S | Ordinary Shares | 10000 | $30.36 | 20,439.0000 | 58,516,415 | 32.85% | 0.02% |
| Nov. 4, 2025 | Kaye Jack | Director | M | Ordinary Shares | 10000 | $7.37 | 30,439.0000 | 58,516,415 | 48.93% | 0.02% |
| Sept. 24, 2025 | Kapusta Matthew C | CEO, Managing Director | M | Ordinary Shares | 175000 | $6.22 | 877,770.0000 | 54,807,967 | 24.90% | 0.32% |
| Sept. 26, 2025 | KLEMT CHRISTIAN | Chief Financial Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 54,807,967 | 100.00% | 0.03% |
| Sept. 26, 2025 | KLEMT CHRISTIAN | Chief Financial Officer | M | Ordinary Shares | 15000 | $5.37 | 232,730.0000 | 54,807,967 | 6.89% | 0.03% |
| Sept. 26, 2025 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 15000 | $55.00 | 217,730.0000 | 54,807,967 | 6.45% | 0.03% |
| Sept. 24, 2025 | KLEMT CHRISTIAN | Chief Financial Officer | M | Stock Option (Right to Buy) | 3000 | $0.00 | 0.0000 | 54,807,967 | 100.00% | 0.01% |
| Sept. 24, 2025 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 3000 | $40.04 | 217,730.0000 | 54,807,967 | 1.36% | 0.01% |
| Sept. 24, 2025 | KLEMT CHRISTIAN | Chief Financial Officer | M | Ordinary Shares | 3000 | $13.03 | 220,730.0000 | 54,807,967 | 1.38% | 0.01% |
| Sept. 24, 2025 | Kapusta Matthew C | CEO, Managing Director | M | Stock Option (Right to Buy) | 175000 | $0.00 | 0.0000 | 54,807,967 | 100.00% | 0.32% |
| Sept. 24, 2025 | Kapusta Matthew C | CEO, Managing Director | M | Stock Option (Right to Buy) | 51316 | $0.00 | 0.0000 | 54,807,967 | 100.00% | 0.09% |
| Sept. 24, 2025 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 60000 | $45.10 | 651,454.0000 | 54,807,967 | 8.43% | 0.11% |
| Sept. 24, 2025 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 5022 | $41.69 | 711,454.0000 | 54,807,967 | 0.70% | 0.01% |
| Sept. 24, 2025 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 49978 | $40.68 | 716,476.0000 | 54,807,967 | 6.52% | 0.09% |
| Sept. 24, 2025 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 60000 | $40.04 | 766,454.0000 | 54,807,967 | 7.26% | 0.11% |
| Sept. 24, 2025 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 51316 | $39.59 | 826,454.0000 | 54,807,967 | 5.85% | 0.09% |
| Sept. 24, 2025 | Kapusta Matthew C | CEO, Managing Director | M | Ordinary Shares | 51316 | $7.53 | 702,770.0000 | 54,807,967 | 7.88% | 0.09% |
| June 27, 2025 | Abi-Saab Walid | Chief Medical Officer | S | Ordinary Shares | 1466 | $13.92 | 150,437.0000 | 53,110,580 | 0.97% | 0.00% |
| June 20, 2025 | Jacques Rachelle Suzanne | Director | S | Ordinary Shares | 2112 | $14.45 | 28,346.0000 | 53,110,580 | 6.93% | 0.00% |
| June 20, 2025 | Springhorn Jeremy P. | Director | S | Ordinary Shares | 2112 | $14.45 | 37,694.0000 | 53,110,580 | 5.31% | 0.00% |
| June 20, 2025 | POST LEONARD E | Director | S | Ordinary Shares | 2112 | $14.45 | 29,937.0000 | 53,110,580 | 6.59% | 0.00% |
| June 20, 2025 | Kaye Jack | Director | S | Ordinary Shares | 2112 | $14.45 | 20,439.0000 | 53,110,580 | 9.37% | 0.00% |
| June 20, 2025 | Meek David D. | Director | S | Ordinary Shares | 2112 | $14.45 | 34,190.0000 | 53,110,580 | 5.82% | 0.00% |
| June 20, 2025 | Balachandran Madhavan | Director | S | Ordinary Shares | 2112 | $14.45 | 37,697.0000 | 53,110,580 | 5.31% | 0.00% |
| June 20, 2025 | Gut Robert | Director | S | Ordinary Shares | 3336 | $14.45 | 56,879.0000 | 53,110,580 | 5.54% | 0.01% |
| June 16, 2025 | Potts Jeannette | Chief Legal Officer | S | Ordinary Shares | 4670 | $15.14 | 115,073.0000 | 53,110,580 | 3.90% | 0.01% |
| June 11, 2025 | Springhorn Jeremy P. | Director | A | Stock Option (Right to Buy) | 15630 | $0.00 | 15,630.0000 | 53,110,580 | 9999.99% | 0.03% |
| June 11, 2025 | Meek David D. | Director | A | Ordinary Shares | 7970 | $0.00 | 36,302.0000 | 53,110,580 | 28.13% | 0.02% |
| June 11, 2025 | Meek David D. | Director | A | Stock Option (Right to Buy) | 15630 | $0.00 | 15,630.0000 | 53,110,580 | 9999.99% | 0.03% |
| June 11, 2025 | POST LEONARD E | Director | A | Ordinary Shares | 7970 | $0.00 | 32,049.0000 | 53,110,580 | 33.10% | 0.02% |
| June 11, 2025 | Kaye Jack | Director | A | Stock Option (Right to Buy) | 15630 | $0.00 | 15,630.0000 | 53,110,580 | 9999.99% | 0.03% |
| June 11, 2025 | POST LEONARD E | Director | A | Stock Option (Right to Buy) | 15630 | $0.00 | 15,630.0000 | 53,110,580 | 9999.99% | 0.03% |
| June 11, 2025 | Kaye Jack | Director | A | Ordinary Shares | 7970 | $0.00 | 22,551.0000 | 53,110,580 | 54.66% | 0.02% |
| June 11, 2025 | Jacques Rachelle Suzanne | Director | A | Ordinary Shares | 7970 | $0.00 | 30,458.0000 | 53,110,580 | 35.44% | 0.02% |
| June 11, 2025 | Jacques Rachelle Suzanne | Director | A | Stock Option (Right to Buy) | 15630 | $0.00 | 15,630.0000 | 53,110,580 | 9999.99% | 0.03% |
| June 11, 2025 | Gut Robert | Director | A | Ordinary Shares | 7970 | $0.00 | 60,215.0000 | 53,110,580 | 15.26% | 0.02% |
| June 11, 2025 | Gut Robert | Director | A | Stock Option (Right to Buy) | 15630 | $0.00 | 15,630.0000 | 53,110,580 | 9999.99% | 0.03% |
| June 11, 2025 | Balachandran Madhavan | Director | A | Ordinary Shares | 7970 | $0.00 | 39,809.0000 | 53,110,580 | 25.03% | 0.02% |
| June 11, 2025 | Springhorn Jeremy P. | Director | A | Ordinary Shares | 7970 | $0.00 | 39,806.0000 | 53,110,580 | 25.03% | 0.02% |
| June 11, 2025 | Balachandran Madhavan | Director | A | Stock Option (Right to Buy) | 15630 | $0.00 | 15,630.0000 | 53,110,580 | 9999.99% | 0.03% |
| March 3, 2025 | Abi-Saab Walid | Chief Medical Officer | A | Ordinary Shares | 38000 | $0.00 | 153,253.0000 | 48,649,129 | 32.97% | 0.08% |
| March 3, 2025 | Kapusta Matthew C | CEO, Managing Director | A | Ordinary Shares | 99000 | $0.00 | 679,795.0000 | 48,649,129 | 17.05% | 0.20% |
| March 4, 2025 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 28341 | $10.29 | 651,454.0000 | 48,649,129 | 4.17% | 0.06% |
| March 3, 2025 | Kapusta Matthew C | CEO, Managing Director | A | Stock Option (Right to Buy) | 171000 | $0.00 | 171,000.0000 | 48,649,129 | 9999.99% | 0.35% |
| March 4, 2025 | Abi-Saab Walid | Chief Medical Officer | S | Ordinary Shares | 1350 | $10.29 | 151,903.0000 | 48,649,129 | 0.88% | 0.00% |
| March 3, 2025 | Abi-Saab Walid | Chief Medical Officer | A | Stock Option (Right to Buy) | 66000 | $0.00 | 66,000.0000 | 48,649,129 | 9999.99% | 0.14% |
| March 3, 2025 | KLEMT CHRISTIAN | Chief Financial Officer | A | Ordinary Shares | 73000 | $0.00 | 228,168.0000 | 48,649,129 | 47.05% | 0.15% |
| March 4, 2025 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 10438 | $10.29 | 217,730.0000 | 48,649,129 | 4.57% | 0.02% |
| March 3, 2025 | KLEMT CHRISTIAN | Chief Financial Officer | A | Stock Option (Right to Buy) | 126000 | $0.00 | 126,000.0000 | 48,649,129 | 9999.99% | 0.26% |
| March 3, 2025 | Potts Jeannette | Chief Legal Officer | A | Ordinary Shares | 35000 | $0.00 | 126,819.0000 | 48,649,129 | 38.12% | 0.07% |
| March 4, 2025 | Potts Jeannette | Chief Legal Officer | S | Ordinary Shares | 7076 | $10.29 | 119,743.0000 | 48,649,129 | 5.58% | 0.01% |
| March 3, 2025 | Potts Jeannette | Chief Legal Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 48,649,129 | 9999.99% | 0.12% |
| Feb. 26, 2025 | Kapusta Matthew C | CEO, Managing Director | A | Ordinary Shares | 16324 | $0.00 | 587,512.0000 | 48,649,129 | 2.86% | 0.03% |
| Feb. 25, 2025 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 26727 | $10.70 | 571,188.0000 | 48,649,129 | 4.47% | 0.05% |
| Feb. 27, 2025 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 2916 | $11.32 | 155,168.0000 | 48,649,129 | 1.84% | 0.01% |
| Feb. 26, 2025 | KLEMT CHRISTIAN | Chief Financial Officer | A | Ordinary Shares | 5712 | $0.00 | 158,084.0000 | 48,649,129 | 3.75% | 0.01% |
| Feb. 25, 2025 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 14341 | $10.70 | 152,372.0000 | 48,649,129 | 8.60% | 0.03% |
| Feb. 27, 2025 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 6717 | $11.32 | 580,795.0000 | 48,649,129 | 1.14% | 0.01% |
| Dec. 10, 2024 | Kapusta Matthew C | CEO, Managing Director | M | Ordinary Shares | 100000 | $14.71 | 697,915.0000 | 48,718,533 | 16.72% | 0.21% |
| Dec. 10, 2024 | Kapusta Matthew C | CEO, Managing Director | M | Stock Option (Right to Buy) | 100000 | $0.00 | 0.0000 | 48,718,533 | 100.00% | 0.21% |
| Dec. 10, 2024 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 100000 | $15.03 | 597,915.0000 | 48,718,533 | 14.33% | 0.21% |
| Dec. 8, 2024 | Kapusta Matthew C | CEO, Managing Director | A | Ordinary Shares | 10494 | $0.00 | 601,333.0000 | 48,718,533 | 1.78% | 0.02% |
| Dec. 9, 2024 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 3418 | $7.63 | 597,915.0000 | 48,718,533 | 0.57% | 0.01% |
| Dec. 9, 2024 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 1796 | $7.55 | 166,713.0000 | 48,718,533 | 1.07% | 0.00% |
| Dec. 8, 2024 | KLEMT CHRISTIAN | Chief Financial Officer | A | Ordinary Shares | 3672 | $0.00 | 168,509.0000 | 48,718,533 | 2.23% | 0.01% |
| June 26, 2024 | Abi-Saab Walid | Chief Medical Officer | S | Ordinary Shares | 1447 | $4.36 | 115,253.0000 | 48,384,510 | 1.24% | 0.00% |
| June 19, 2024 | POST LEONARD E | Director | A | Stock Option (Right to Buy) | 15840 | $0.00 | 15,840.0000 | 48,384,510 | 9999.99% | 0.03% |
| June 19, 2024 | Jacques Rachelle Suzanne | Director | A | Stock Option (Right to Buy) | 15840 | $0.00 | 15,840.0000 | 48,384,510 | 9999.99% | 0.03% |
| June 19, 2024 | Gut Robert | Director | A | Ordinary Shares | 8080 | $0.00 | 52,245.0000 | 48,384,510 | 18.30% | 0.02% |
| June 19, 2024 | Gut Robert | Director | A | Stock Option (Right to Buy) | 15840 | $0.00 | 15,840.0000 | 48,384,510 | 9999.99% | 0.03% |
| June 19, 2024 | Springhorn Jeremy P. | Director | A | Ordinary Shares | 8080 | $0.00 | 31,836.0000 | 48,384,510 | 34.01% | 0.02% |
| June 19, 2024 | Springhorn Jeremy P. | Director | A | Stock Option (Right to Buy) | 15840 | $0.00 | 15,840.0000 | 48,384,510 | 9999.99% | 0.03% |
| June 19, 2024 | Meek David D. | Director | A | Ordinary Shares | 8080 | $0.00 | 28,332.0000 | 48,384,510 | 39.90% | 0.02% |
| June 19, 2024 | Meek David D. | Director | A | Stock Option (Right to Buy) | 15840 | $0.00 | 15,840.0000 | 48,384,510 | 9999.99% | 0.03% |
| June 19, 2024 | Balachandran Madhavan | Director | A | Ordinary Shares | 8080 | $0.00 | 31,839.0000 | 48,384,510 | 34.01% | 0.02% |
| June 19, 2024 | Balachandran Madhavan | Director | A | Stock Option (Right to Buy) | 15840 | $0.00 | 15,840.0000 | 48,384,510 | 9999.99% | 0.03% |
| June 19, 2024 | Kaye Jack | Director | A | Ordinary Shares | 8080 | $0.00 | 14,581.0000 | 48,384,510 | 124.29% | 0.02% |
| June 19, 2024 | Kaye Jack | Director | A | Stock Option (Right to Buy) | 15840 | $0.00 | 15,840.0000 | 48,384,510 | 9999.99% | 0.03% |
| June 19, 2024 | POST LEONARD E | Director | A | Ordinary Shares | 8080 | $0.00 | 24,079.0000 | 48,384,510 | 50.50% | 0.02% |
| June 19, 2024 | Jacques Rachelle Suzanne | Director | A | Ordinary Shares | 8080 | $0.00 | 22,488.0000 | 48,384,510 | 56.08% | 0.02% |
| June 17, 2024 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 1611 | $4.80 | 164,837.0000 | 48,384,510 | 0.97% | 0.00% |
| June 17, 2024 | CALOZ PIERRE | Chief Operating Officer | S | Ordinary Shares | 2936 | $4.81 | 115,707.0000 | 48,384,510 | 2.47% | 0.01% |
| June 13, 2024 | POST LEONARD E | Director | S | Ordinary Shares | 2222 | $5.14 | 15,999.0000 | 48,384,510 | 12.19% | 0.00% |
| June 13, 2024 | Soteropoulos Paula | Director | S | Ordinary Shares | 2220 | $5.14 | 20,203.0000 | 48,384,510 | 9.90% | 0.00% |
| June 13, 2024 | Balachandran Madhavan | Director | S | Ordinary Shares | 2231 | $5.12 | 23,759.0000 | 48,384,510 | 8.58% | 0.00% |
| June 13, 2024 | Meek David D. | Director | S | Ordinary Shares | 2229 | $5.12 | 20,252.0000 | 48,384,510 | 9.92% | 0.00% |
| June 13, 2024 | Springhorn Jeremy P. | Director | S | Ordinary Shares | 2231 | $5.12 | 23,756.0000 | 48,384,510 | 8.59% | 0.00% |
| June 13, 2024 | Potts Jeannette | Chief Legal Officer | S | Ordinary Shares | 4781 | $4.98 | 91,819.0000 | 48,384,510 | 4.95% | 0.01% |
| June 13, 2024 | Jacques Rachelle Suzanne | Director | S | Ordinary Shares | 2221 | $5.14 | 14,408.0000 | 48,384,510 | 13.36% | 0.00% |
| June 13, 2024 | Gut Robert | Director | S | Ordinary Shares | 3504 | $5.12 | 44,165.0000 | 48,384,510 | 7.35% | 0.01% |
| June 13, 2024 | Kaye Jack | Director | S | Ordinary Shares | 2218 | $5.16 | 6,501.0000 | 48,384,510 | 25.44% | 0.00% |
| March 1, 2024 | Kapusta Matthew C | CEO, Managing Director | A | Ordinary Shares | 150000 | $0.00 | 590,839.0000 | 47,670,986 | 34.03% | 0.31% |
| March 1, 2024 | KLEMT CHRISTIAN | Chief Financial Officer | A | Ordinary Shares | 49500 | $0.00 | 166,448.0000 | 47,670,986 | 42.33% | 0.10% |
| March 1, 2024 | KLEMT CHRISTIAN | Chief Financial Officer | A | Stock Option (Right to Buy) | 85500 | $0.00 | 85,500.0000 | 47,670,986 | 9999.99% | 0.18% |
| March 1, 2024 | Abi-Saab Walid | Chief Medical Officer | A | Ordinary Shares | 49500 | $0.00 | 116,700.0000 | 47,670,986 | 73.66% | 0.10% |
| March 1, 2024 | Abi-Saab Walid | Chief Medical Officer | A | Stock Option (Right to Buy) | 85500 | $0.00 | 85,500.0000 | 47,670,986 | 9999.99% | 0.18% |
| March 1, 2024 | CALOZ PIERRE | Chief Operating Officer | A | Ordinary Shares | 33000 | $0.00 | 118,643.0000 | 47,670,986 | 38.53% | 0.07% |
| March 1, 2024 | CALOZ PIERRE | Chief Operating Officer | A | Stock Option (Right to Buy) | 57000 | $0.00 | 57,000.0000 | 47,670,986 | 9999.99% | 0.12% |
| March 1, 2024 | Potts Jeannette | Chief Legal Officer | A | Ordinary Shares | 49500 | $0.00 | 96,600.0000 | 47,670,986 | 105.10% | 0.10% |
| March 1, 2024 | Potts Jeannette | Chief Legal Officer | A | Stock Option (Right to Buy) | 85500 | $0.00 | 85,500.0000 | 47,670,986 | 9999.99% | 0.18% |
| March 1, 2024 | Kapusta Matthew C | CEO, Managing Director | A | Stock Option (Right to Buy) | 259500 | $0.00 | 259,500.0000 | 47,670,986 | 9999.99% | 0.54% |
| Feb. 26, 2024 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 15906 | $6.38 | 116,948.0000 | 47,670,986 | 11.97% | 0.03% |
| Feb. 26, 2024 | CALOZ PIERRE | Chief Operating Officer | S | Ordinary Shares | 9455 | $6.47 | 85,643.0000 | 47,670,986 | 9.94% | 0.02% |
| Feb. 26, 2024 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 27904 | $6.35 | 440,839.0000 | 47,670,986 | 5.95% | 0.06% |
| June 23, 2023 | Kaye Jack | Director | G | Ordinary Shares | 12700 | $0.00 | 8,719.0000 | 47,436,335 | 59.29% | 0.03% |
| June 23, 2023 | Kaye Jack | Director | G | Ordinary Shares | 12700 | $0.00 | 21,419.0000 | 47,436,335 | 37.22% | 0.03% |
| Sept. 18, 2023 | Dolmetsch Ricardo | President, R&D | S | Ordinary Shares | 5841 | $7.46 | 163,404.0000 | 47,649,520 | 3.45% | 0.01% |
| July 10, 2023 | CALOZ PIERRE | Chief Operating Officer | S | Ordinary Shares | 15117 | $11.36 | 95,098.0000 | 47,649,520 | 13.72% | 0.03% |
| June 13, 2023 | Meek David D. | Director | A | Ordinary Shares | 8700 | $0.00 | 24,771.0000 | 47,436,335 | 54.13% | 0.02% |
| June 16, 2023 | Meek David D. | Director | S | Ordinary Shares | 2290 | $18.85 | 22,481.0000 | 47,436,335 | 9.24% | 0.00% |
| June 13, 2023 | Meek David D. | Director | A | Stock Option (Right to Buy) | 17060 | $0.00 | 17,060.0000 | 47,436,335 | 9999.99% | 0.04% |
| June 13, 2023 | Kaye Jack | Director | A | Ordinary Shares | 8700 | $0.00 | 36,399.0000 | 47,436,335 | 31.41% | 0.02% |
| June 16, 2023 | Kaye Jack | Director | S | Ordinary Shares | 2280 | $18.93 | 34,119.0000 | 47,436,335 | 6.26% | 0.00% |
| June 13, 2023 | Springhorn Jeremy P. | Director | A | Stock Option (Right to Buy) | 17060 | $0.00 | 17,060.0000 | 47,436,335 | 9999.99% | 0.04% |
| June 16, 2023 | Springhorn Jeremy P. | Director | S | Ordinary Shares | 2286 | $18.88 | 25,987.0000 | 47,436,335 | 8.09% | 0.00% |
| June 13, 2023 | Springhorn Jeremy P. | Director | A | Ordinary Shares | 8700 | $0.00 | 28,273.0000 | 47,436,335 | 44.45% | 0.02% |
| June 16, 2023 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 1587 | $18.94 | 132,854.0000 | 47,436,335 | 1.18% | 0.00% |
| June 16, 2023 | CALOZ PIERRE | Chief Operating Officer | S | Ordinary Shares | 2920 | $18.80 | 110,215.0000 | 47,436,335 | 2.58% | 0.01% |
| June 13, 2023 | Balachandran Madhavan | Director | A | Stock Option (Right to Buy) | 17060 | $0.00 | 17,060.0000 | 47,436,335 | 9999.99% | 0.04% |
| June 16, 2023 | Balachandran Madhavan | Director | S | Ordinary Shares | 2283 | $18.91 | 25,990.0000 | 47,436,335 | 8.07% | 0.00% |
| June 13, 2023 | Balachandran Madhavan | Director | A | Ordinary Shares | 8700 | $0.00 | 28,273.0000 | 47,436,335 | 44.45% | 0.02% |
| June 13, 2023 | Gut Robert | Director | A | Stock Option (Right to Buy) | 17060 | $0.00 | 17,060.0000 | 47,436,335 | 9999.99% | 0.04% |
| June 16, 2023 | Gut Robert | Director | S | Ordinary Shares | 3228 | $18.88 | 47,669.0000 | 47,436,335 | 6.34% | 0.01% |
| June 13, 2023 | Gut Robert | Director | A | Ordinary Shares | 8700 | $0.00 | 50,897.0000 | 47,436,335 | 20.62% | 0.02% |
| June 13, 2023 | Kaye Jack | Director | A | Stock Option (Right to Buy) | 17060 | $0.00 | 17,060.0000 | 47,436,335 | 9999.99% | 0.04% |
| June 13, 2023 | POST LEONARD E | Director | A | Ordinary Shares | 8700 | $0.00 | 20,512.0000 | 47,436,335 | 73.65% | 0.02% |
| June 13, 2023 | POST LEONARD E | Director | A | Stock Option (Right to Buy) | 17060 | $0.00 | 17,060.0000 | 47,436,335 | 9999.99% | 0.04% |
| June 13, 2023 | Jacques Rachelle Suzanne | Director | A | Ordinary Shares | 8700 | $0.00 | 18,930.0000 | 47,436,335 | 85.04% | 0.02% |
| June 16, 2023 | Jacques Rachelle Suzanne | Director | S | Ordinary Shares | 2301 | $18.76 | 16,629.0000 | 47,436,335 | 12.16% | 0.00% |
| June 13, 2023 | Jacques Rachelle Suzanne | Director | A | Stock Option (Right to Buy) | 17060 | $0.00 | 17,060.0000 | 47,436,335 | 9999.99% | 0.04% |
| June 13, 2023 | Soteropoulos Paula | Director | A | Ordinary Shares | 8700 | $0.00 | 24,698.0000 | 47,436,335 | 54.38% | 0.02% |
| June 16, 2023 | Soteropoulos Paula | Director | S | Ordinary Shares | 2275 | $18.99 | 22,423.0000 | 47,436,335 | 9.21% | 0.00% |
| June 13, 2023 | Soteropoulos Paula | Director | A | Stock Option (Right to Buy) | 17060 | $0.00 | 17,060.0000 | 47,436,335 | 9999.99% | 0.04% |
| June 16, 2023 | POST LEONARD E | Director | S | Ordinary Shares | 2291 | $18.83 | 18,221.0000 | 47,436,335 | 11.17% | 0.00% |
| June 13, 2023 | Potts Jeannette | See Remarks | A | Option (Right to Buy) | 81300 | $0.00 | 81,300.0000 | 47,436,335 | 9999.99% | 0.17% |
| June 13, 2023 | Potts Jeannette | See Remarks | A | Ordinary Shares | 47100 | $0.00 | 47,100.0000 | 47,436,335 | 9999.99% | 0.10% |
| March 7, 2023 | CALOZ PIERRE | Chief Operating Officer | S | Ordinary Shares | 990 | $21.33 | 113,135.0000 | 46,735,045 | 0.87% | 0.00% |
| March 7, 2023 | Dolmetsch Ricardo | President, R&D | S | Ordinary Shares | 837 | $21.04 | 169,245.0000 | 46,735,045 | 0.49% | 0.00% |
| March 7, 2023 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 2521 | $21.39 | 468,743.0000 | 46,735,045 | 0.53% | 0.01% |
| March 7, 2023 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 986 | $21.36 | 134,441.0000 | 46,735,045 | 0.73% | 0.00% |
| March 7, 2023 | Kuta Alexander Edward III | Executive VP, Operations | S | Ordinary Shares | 585 | $21.36 | 90,381.0000 | 46,735,045 | 0.64% | 0.00% |
| Feb. 27, 2023 | Dolmetsch Ricardo | President, R&D | S | Ordinary Shares | 6944 | $19.58 | 170,082.0000 | 46,735,045 | 3.92% | 0.01% |
| Feb. 27, 2023 | POST LEONARD E | Director | S | Ordinary Shares | 389 | $19.73 | 11,812.0000 | 46,735,045 | 3.19% | 0.00% |
| Feb. 27, 2023 | Kuta Alexander Edward III | Executive VP, Operations | S | Ordinary Shares | 5514 | $19.99 | 92,178.0000 | 46,735,045 | 5.64% | 0.01% |
| Feb. 28, 2023 | Kuta Alexander Edward III | Executive VP, Operations | S | Ordinary Shares | 1212 | $21.04 | 90,966.0000 | 46,735,045 | 1.31% | 0.00% |
| Feb. 27, 2023 | Balachandran Madhavan | Director | S | Ordinary Shares | 384 | $19.99 | 19,573.0000 | 46,735,045 | 1.92% | 0.00% |
| Feb. 27, 2023 | Soteropoulos Paula | Director | S | Ordinary Shares | 384 | $19.97 | 15,998.0000 | 46,735,045 | 2.34% | 0.00% |
| Feb. 27, 2023 | CALOZ PIERRE | Chief Operating Officer | S | Ordinary Shares | 4284 | $19.59 | 114,206.0000 | 46,735,045 | 3.62% | 0.01% |
| Feb. 27, 2023 | CALOZ PIERRE | Chief Operating Officer | S | Ordinary Shares | 81 | $20.80 | 114,125.0000 | 46,735,045 | 0.07% | 0.00% |
| Feb. 27, 2023 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 9824 | $20.10 | 136,796.0000 | 46,735,045 | 6.70% | 0.02% |
| Feb. 28, 2023 | KLEMT CHRISTIAN | Chief Financial Officer | S | Ordinary Shares | 1369 | $20.90 | 135,427.0000 | 46,735,045 | 1.00% | 0.00% |
| Feb. 27, 2023 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 18141 | $19.86 | 477,670.0000 | 46,735,045 | 3.66% | 0.04% |
| Feb. 27, 2023 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 1385 | $20.24 | 476,285.0000 | 46,735,045 | 0.29% | 0.00% |
| Feb. 28, 2023 | Kapusta Matthew C | CEO, Managing Director | S | Ordinary Shares | 5021 | $20.90 | 471,264.0000 | 46,735,045 | 1.05% | 0.01% |
| Feb. 27, 2023 | Springhorn Jeremy P. | Director | S | Ordinary Shares | 384 | $20.41 | 19,573.0000 | 46,735,045 | 1.92% | 0.00% |
| Feb. 27, 2023 | Jacques Rachelle Suzanne | Director | S | Ordinary Shares | 384 | $20.02 | 10,230.0000 | 46,735,045 | 3.62% | 0.00% |
| Feb. 27, 2023 | Kaye Jack | Director | S | Ordinary Shares | 384 | $19.99 | 27,699.0000 | 46,735,045 | 1.37% | 0.00% |
| Feb. 27, 2023 | Meek David D. | Director | S | Ordinary Shares | 389 | $19.71 | 16,071.0000 | 46,735,045 | 2.36% | 0.00% |
| Feb. 27, 2023 | Gut Robert | Director | S | Ordinary Shares | 537 | $19.79 | 43,628.0000 | 46,735,045 | 1.22% | 0.00% |
| Feb. 28, 2023 | Gut Robert | Director | S | Ordinary Shares | 1431 | $21.16 | 42,197.0000 | 46,735,045 | 3.28% | 0.00% |
| Feb. 23, 2023 | KLEMT CHRISTIAN | Chief Financial Officer | A | Ordinary Shares | 37400 | $0.00 | 146,620.0000 | 46,735,045 | 34.24% | 0.08% |
| Feb. 23, 2023 | Dolmetsch Ricardo | President, R&D | A | Stock Option (Right to Buy) | 80600 | $0.00 | 80,600.0000 | 46,735,045 | 9999.99% | 0.17% |
| Feb. 23, 2023 | Dolmetsch Ricardo | President, R&D | A | Ordinary Shares | 46700 | $0.00 | 177,026.0000 | 46,735,045 | 35.83% | 0.10% |
| Feb. 23, 2023 | CALOZ PIERRE | Chief Operating Officer | A | Stock Option (Right to Buy) | 80600 | $0.00 | 80,600.0000 | 46,735,045 | 9999.99% | 0.17% |
| Feb. 23, 2023 | CALOZ PIERRE | Chief Operating Officer | A | Ordinary Shares | 46700 | $0.00 | 118,490.0000 | 46,735,045 | 65.05% | 0.10% |
| Feb. 23, 2023 | Kapusta Matthew C | CEO, Managing Director | A | Stock Option (Right to Buy) | 256500 | $0.00 | 256,500.0000 | 46,735,045 | 9999.99% | 0.55% |
| Feb. 23, 2023 | Kapusta Matthew C | CEO, Managing Director | A | Ordinary Shares | 121500 | $0.00 | 495,811.0000 | 46,735,045 | 32.46% | 0.26% |
| Feb. 23, 2023 | KLEMT CHRISTIAN | Chief Financial Officer | A | Stock Option (Right to Buy) | 64500 | $0.00 | 64,500.0000 | 46,735,045 | 9999.99% | 0.14% |
| Feb. 20, 2023 | CALOZ PIERRE | Chief Operating Officer | A | Ordinary Shares | 2920 | $0.00 | 71,790.0000 | 46,735,045 | 4.24% | 0.01% |
| Feb. 20, 2023 | KLEMT CHRISTIAN | Chief Financial Officer | A | Ordinary Shares | 2040 | $0.00 | 109,220.0000 | 46,735,045 | 1.90% | 0.00% |
| Feb. 20, 2023 | Kapusta Matthew C | CEO, Managing Director | A | Ordinary Shares | 5830 | $0.00 | 374,311.0000 | 46,735,045 | 1.58% | 0.01% |
| Feb. 20, 2023 | Dolmetsch Ricardo | President, R&D | A | Ordinary Shares | 2920 | $0.00 | 130,326.0000 | 46,735,045 | 2.29% | 0.01% |
| Feb. 20, 2023 | Kuta Alexander Edward III | Executive VP, Operations | A | Ordinary Shares | 2040 | $0.00 | 97,692.0000 | 46,735,045 | 2.13% | 0.00% |
| Jan. 18, 2023 | Soteropoulos Paula | Director | S | Ordinary Shares | 6000 | $22.59 | 16,382.0000 | 46,735,045 | 26.81% | 0.01% |
| Jan. 18, 2023 | Soteropoulos Paula | Director | M | Ordinary Shares | 6000 | $5.37 | 22,382.0000 | 46,735,045 | 36.63% | 0.01% |
| Jan. 18, 2023 | Soteropoulos Paula | Director | M | Stock Option (Right to Buy) | 6000 | $0.00 | 2,000.0000 | 46,735,045 | 75.00% | 0.01% |